Gmr Solutions Inc. · NYSE:GMRS
Gmr Solutions — Q1 2026 Earnings Presentation
28 slides from Gmr Solutions's earnings presentation, Jun 2, 2026
Slide 1: Q1 2026 Earnings Presentation
Q1 2026 Earnings Presentation June 2, 2026
Slide 2: Disclaimers
Disclaimers Forward-Looking Statements: This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our operations and financial per
Slide 3: GMR Solutions Inc. ("GMR") at a Glance
GMR Solutions Inc. (“GMR”) at a Glance GMR TODAY(1) Who We Are Largest provider of Emergency Medical Services (“EMS”) and one of the largest mobile clinical Annual Patient Encounters Delivering Emergent care practice groups globally What We Do U.S. Population Coverage U.S. Counties Served Naviga
Slide 4: We Deliver Critical Care at Scale Across the U.S. & Globally
We Deliver Critical Care at Scale Across the U.S. & Globally The scale, depth and pace at which we operate is unmatched An Average Day at GMR 15.0K 114 178 133 Cardiac Arrest Responses Emergency Stroke Patients Critically Injured Trauma Daily Patient Encounters Patient Transports 683 263 Blood Gluco
Slide 5: Highlights
Highlights Q1 Highlights Net Revenues of $1,457.6 million, an increase of 6.6% compared to the prior year quarter Net Income of $106.3 million, an increase of 179.7% Adjusted EBITDA of $305.1 million, an increase of 9.7% Maintained a strong liquidity position, finishing the quarter with $426
Slide 6: Q1 2026 Financial Highlights
Q1 2026 Financial Highlights Three months ended March 31, 2026 Revenue ($mm) Adj. EBITDA ($mm) Highlights Total Revenue Growth of 6.6% driven by $1,458 0.7% increase in emergent transports and $1,367 7.9% improvement in NRT(1) Same-market revenue growth of 7.9% Key performance indicators 1,3
Slide 7: Q1 2026 Cash Flow and Balance Sheet Update
Q1 2026 Cash Flow and Balance Sheet Update LTM Pro Forma Net Liquidity Post-IPO ($mm) Leverage Post-IPO and Private Placement (2) Cash and cash equivalents ABL capacity (1) GMR maintains significant liquidity to execute from a position of Cash and cash equivalents strength $1,118 $426 million of
Slide 8: 2026 Guidance
2026 Guidance 2026 Net Revenue 2026 Adj. EBITDA(1) Of Revenue for Net Cash CAPEX and Aircraft Financing 8 (1) A reconciliation of the guidance for Adjusted EBITDA to GAAP net income cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurr
Slide 9: Our Capital Allocation Framework
Our Capital Allocation Framework 1 Planned Investments to Support Organic Growth 2 Deleveraging Order of priority 3 Strategic Investments in Organic and Inorganic Growth Opportunities 4 Return of Capital 9
Slide 10: Company Overview
Company Overview
Slide 11: We Provide Rapid Care for Patients, and Navigate Them to the Most Appropriate Site of Care
We Provide Rapid Care for Patients, and Navigate Them to the Most Appropriate Site of Care GMR treats patients …delivers lifesaving care …and connects them to the right where they are… at their most critical moments… level of care if needed Skilled clinical staff Emergency At Home made up of nurses,
Slide 12: We Play a Critical Role in Care Delivery at the Time Patients Need Us the Most
We Play a Critical Role in Care Delivery at the Time Patients Need Us the Most Unplanned Care Planned Care Emergent Care Disaster Response Event Medical Non-Emergent Care Unplanned scene Disaster response in partnership EMS presence at live Scheduled patient requests or interfacility with the larges
Slide 13: We Have Evolved From an Air and Ground Care Provider to an Integrated Provider
We Have Evolved From an Air and Ground Care Provider to an Integrated Provider Influencing Site of Care, Cost, Quality and Population Health GMR Evolution Integrated Emergent, Non-Emergent, Innovative solutions delivering the right Air + Ground Medical Provider (2018) Event Medical + Disaster Respon
Slide 14: We Have a Long Track Record of Consistent Growth
We Have a Long Track Record of Consistent Growth We operate in the EMS industry, which has grown and is expected to continue to grow at 5-7% annually Given our national scale, the breadth and depth of our capabilities, and the integrated nature of our business, we believe we have the right to ca
Slide 15: GMR Summary
GMR Summary 1 Operate in an Essential, Large and Growing Market with Significant Structural Tailwinds 2 Only National, Fully-Integrated Provider of Emergent Care at Scale 3 Pioneer of New Care Delivery Models to Reduce Cost and Optimize Access 4 Deliver Meaningful Value to Patients, Communities, Hea
Slide 16: We Serve an Essential ~$35B Total Addressable Market
1 We Serve an Essential ~$35B Total Addressable Market Differentiated Trifecta Enables Relevant Markets SAM Capture… Serviceable Addressable Market Excludes TAM serviced by municipalities and gov’t agencies Fragmented Significant Expanding Core Market Scale Capabilities Total Addressable Market Emer
Slide 17: We Leverage Our Extensive Integrated Clinical, Fleet and Support Resources
2 We Leverage Our Extensive Integrated Clinical, Fleet and Support Resources to Deliver High-Quality Care at Scale A Diverse and Expansive ~34K Workforce Substantial Ambulance Fleet Utilized by Clinicians ~22.5K ~22.0KEMTs EMTs/ / ~7,300 ~7.3K ~7.3KGround Ground Paramedics Paramedics Ambulances Vehi
Slide 18: We have a Nationwide Footprint, with Significant Potential for Continued Expansion and Cross-Sell
2 We have a Nationwide Footprint, with Significant Potential for Continued Expansion and Cross-Sell Nationwide Coverage of ~60% of the Population Across ~1,400 Counties Coverage in 50 States Counties Covered 211 Integrated Coverage 1,042 Air Coverage 109 Ground Coverage 1,781 No Coverage • Omnichann
Slide 19: Our Transformative Innovations are Unlocking New Vectors for Growth
3 Our Transformative Innovations are Unlocking New Vectors for Growth Nurse Navigation Concierge Model Transport.Net Dedicated nurses embedded in the 911 Reservation based transport that Proprietary online transport portal call intake process guarantees time / availability integrated with 911
Slide 20: We Deliver Significant Value to Our Stakeholders
4 We Deliver Significant Value to Our Stakeholders Health Patients Communities Payors Systems Access to healthcare, often Essential Community Key clinical and operational Quality and value, delivering times only access to care Service and Safety Net, partner, extension of health most appropr
Slide 21: Our Multi-Pronged Strategy Drives Consistent and Robust Growth
5 Our Multi-Pronged Strategy Drives Consistent and Robust Growth A Bid for new or B Sign new C Redeploy assets D Build new air Grow Presence in Existing Markets expanded RFPs health system to capture bases in existing partnerships incremental volumes markets Deploy our Innovations to Capture New Vol
Slide 22: Appendix
e%e6 Global Medical $s Response. Appendix
Slide 23: Income Statement
Income Statement (unaudited, in thousands) Three Months Ended March 31, 2025 2026 Net revenue $1,367,407 $1,457,576 Employee wages, benefits and taxes 734,758 770,006 Maintenance, fuel and other direct expenses 111,811 118,620 Insurance expense 33,652 42,979 Other operating expenses 215,806 228,094
Slide 24: Balance Sheet
Balance Sheet (unaudited, in thousands) December 31, 2025 March 31, 2026 Cash and cash equivalents $609,349 $426,092 Insurance collateral 78,608 74,396 Accounts receivable, net 1,094,814 1,159,661 Spare parts, medical supplies and fuel 115,725 123,772 Prepaid expenses 105,014 75,808 Other current as
Slide 25: Summary Cash Flow Statement Proforma IPO Leverage Calculation
Summary Cash Flow Statement (unaudited, in thousands) Three Months Ended March 31, 2025 2026 Net cash provided by (used in): Operating activities 189,343 128,743 Investing activities (48,416) (51,458) Financing activities (29,079) (264,820) (Decrease) increase in cash, cash equivalents, restricted c
Slide 26: Reconciliations of EBITDA and Adjusted EBITDA to Net Income
Reconciliations of EBITDA and Adjusted EBITDA to Net Income (unaudited, in thousands) TTM Three Months Ended September 30, March 31, 2026 March 31, 2026 December 31, 2025 June 30, 2025 March 31, 2025 2025 Net revenue $5,829,945 $1,457,576 $1,423,490 $1,506,868 $1,442,011 $1,367,407 Net income (loss)
Slide 27: Since 2017, GMR has celebrated the lifesaving care our clinicians provide with the Tomorrow Wall
Since 2017, GMR has celebrated the lifesaving care our clinicians provide everyday with the Tomorrow Wall® Each plaque on the Tomorrow Wall represents one local patient who was successfully resuscitated and discharged from the hospital with no neurological deficits. These walls, which are found at o
Slide 28: Global Medical Response
Global Medical Response